Literature DB >> 6153274

The degradation of human lung elastin by neutrophil proteinases.

C F Reilly, J Travis.   

Abstract

Human lung elastin has been isolated by both a degradative and nondegradative procedure and the products obtained found to have amino acid compositions comparable to published results. These elastin preparations, when utilized as substrates for various mammalian proteinases, were solubilized by porcine elastase at a rate six times faster than human leukocyte elastase. Leukocyte cathepsin G also solubilized lung elastin but only at 12% of the rate of the leukocyte elastase. In all cases the elastin prepared by nondegradative techniques proved to be the best substrate in these studies. The differences in the rate of digestion of elastin of the two elastolytic proteinases was readily attributed to the specificity differences of each enzyme as judged by carboxyterminal analysis of solubilized elastin peptides. The plasma proteinase inhibitors, alpha-1-proteinase inhibitor and alpha-2-macroglobulin abolished the elastolytic activity of both leukocyte enzymes, while alpha-1-antichymotrypsin specifically inactivated cathespsin G. Two synthetic inhibitors, Me-O-Suc-Ala-Ala-Pro-Val-CH2Cl (for elastase and Z-Gly-Leu-Phe-CH2Cl (for cathepsin G) were equally effective in abolishing the elastolytic activity of the two neutrophil enzymes. However, inhibition of leukocyte elastase by alpha-1-proteinase inhibitor was significantly suppressed if the enzyme was preincubated with elastin prior to addition of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6153274     DOI: 10.1016/0005-2795(80)90070-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  29 in total

1.  Plasma leucocyte elastase concentrations in smokers.

Authors:  C R Hind; H Joyce; G A Tennent; M B Pepys; N B Pride
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 2.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Activation of human neutrophil gelatinase by endogenous serine proteinases.

Authors:  M C Vissers; C C Winterbourn
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

4.  Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

Authors:  R C Kao; N G Wehner; K M Skubitz; B H Gray; J R Hoidal
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

5.  Cathepsin G and thrombin: evidence for two different platelet receptors.

Authors:  M A Selak
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

6.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

7.  Human bronchial leucocyte proteinase inhibitor. Rapid isolation and kinetic analysis with human leucocyte proteinases.

Authors:  C E Smith; D A Johnson
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

8.  Immunolocalization of elastase in human emphysematous lungs.

Authors:  V V Damiano; A Tsang; U Kucich; W R Abrams; J Rosenbloom; P Kimbel; M Fallahnejad; G Weinbaum
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

9.  Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs.

Authors:  H M Morrison; S C Afford; R A Stockley
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

10.  Primary structure of human neutrophil elastase.

Authors:  S Sinha; W Watorek; S Karr; J Giles; W Bode; J Travis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.